364 related articles for article (PubMed ID: 8382256)
1. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.
Estrov Z; Kurzrock R; Pocsik E; Pathak S; Kantarjian HM; Zipf TF; Harris D; Talpaz M; Aggarwal BB
J Exp Med; 1993 Mar; 177(3):763-74. PubMed ID: 8382256
[TBL] [Abstract][Full Text] [Related]
2. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
[TBL] [Abstract][Full Text] [Related]
3. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor and lymphotoxin. Qualitative and quantitative differences in the mediation of early and late cellular response.
Chaturvedi MM; LaPushin R; Aggarwal BB
J Biol Chem; 1994 May; 269(20):14575-83. PubMed ID: 8182064
[TBL] [Abstract][Full Text] [Related]
5. Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF.
Estrov Z; Talpaz M; Ku S; Harris D; LaPushin R; Koller CA; Hirsh-Ginsberg C; Huh Y; Yee G; Kurzrock R
Leukemia; 1996 Sep; 10(9):1534-43. PubMed ID: 8751477
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ligand binding and antiproliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of recombinant P60 and P80 receptors.
Higuchi M; Aggarwal BB
Biochem Biophys Res Commun; 1992 Jan; 182(2):638-43. PubMed ID: 1310388
[TBL] [Abstract][Full Text] [Related]
7. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
[TBL] [Abstract][Full Text] [Related]
8. Modulation of two forms of tumor necrosis factor receptors and their cellular response by soluble receptors and their monoclonal antibodies.
Higuchi M; Aggarwal BB
J Biol Chem; 1992 Oct; 267(29):20892-9. PubMed ID: 1328214
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C regulates secretion of lymphotoxin (LT/TNF beta) and TNF alpha by human EBV-transformed B cells.
Jochems GJ; Klein MR; Zeijlemaker WP; van Lier RA
Hum Antibodies Hybridomas; 1992 Oct; 3(4):162-7. PubMed ID: 1335785
[TBL] [Abstract][Full Text] [Related]
10. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
Browning J; Ribolini A
J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
[TBL] [Abstract][Full Text] [Related]
11. B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia: II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts.
Attias D; Grunberger T; Vanek W; Estrov Z; Cohen A; Lau R; Freedman MH
Leukemia; 1995 May; 9(5):884-8. PubMed ID: 7769852
[TBL] [Abstract][Full Text] [Related]
12. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
Janssen O; Gillis S; Kabelitz D
Eur J Immunol; 1990 Jan; 20(1):7-14. PubMed ID: 2155117
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells.
Boussiotis VA; Nadler LM; Strominger JL; Goldfeld AE
Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7007-11. PubMed ID: 7518925
[TBL] [Abstract][Full Text] [Related]
14. Lymphotoxin-alpha is an important autocrine factor for CD40 + interleukin-4-mediated B-cell activation in normal and atopic donors.
Worm M; Ebermayer K; Henz B
Immunology; 1998 Jul; 94(3):395-402. PubMed ID: 9767423
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.
Suzumiya J; Ohshima K; Kanda M; Kumagawa M; Nagano M; Hirata M; Nawa Y; Tamura K; Kikuchi M
Leuk Lymphoma; 2000 May; 37(5-6):593-604. PubMed ID: 11042520
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
McClain K; Estrov Z; Raju U; Kelley PK; Aggarwal BB
Methods; 1997 Jan; 11(1):83-7. PubMed ID: 8990093
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor secreted by transformed human B lymphocytes: lack of an autocrine growth effect.
Pirisi M; Vasiliadis D; Harrison LC
Lymphokine Res; 1990; 9(1):27-33. PubMed ID: 2157923
[TBL] [Abstract][Full Text] [Related]
18. Lymphotoxin-alpha is an autocrine growth factor for chronic lymphocytic leukemia B cells.
Kulmburg P; Radke M; Digel W
Leukemia; 1998 Apr; 12(4):493-8. PubMed ID: 9557606
[TBL] [Abstract][Full Text] [Related]
19. Respective effects of soluble interleukin-1 receptor and tumour necrosis factor receptor on IL-1 and TNF-alpha-induced DNA synthesis of common acute lymphoblastic leukaemia blasts in vitro.
Carter A; Haddad N; Draxler I; Israeli E; Raz B; Tatarsky I
Br J Haematol; 1994 Jan; 86(1):22-9. PubMed ID: 8011537
[TBL] [Abstract][Full Text] [Related]
20. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders.
Trentin L; Zambello R; Agostini C; Siviero F; Adami F; Marcolongo R; Raimondi R; Chisesi T; Pizzolo G; Semenzato G
Blood; 1993 Feb; 81(3):752-8. PubMed ID: 8381309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
